Combined Cytosine Deaminase Expression, 5-Fluorocytosine Exposure, and Radiotherapy Increases Cytotoxicity to Cholangiocarcinoma Cells

Journal of Gastrointestinal Surgery

Volumn 2, Issue 3, 1998, Pages 283-291

  Pederson, Lee C ^a   Vickers, Selwyn M ^a   Buchsbaum, Donald J ^b   Kancharla, Sreekanth R ^b   Mayo, Matthew S ^c   Curiel, David T ^c   Stackhouse, Murray A ^b  

^a Kentucky   (United States)

^b The University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; CYTOSINE DEAMINASE; DEAMINASE; FLUCYTOSINE; FLUOROURACIL; PRODRUG;

ADENOVIRUS; ARTICLE; BILE DUCT CARCINOMA; BILE DUCT TUMOR; CELL CULTURE; GENE THERAPY; GENE VECTOR; HUMAN; MEGAVOLTAGE RADIOTHERAPY; METABOLISM; METHODOLOGY; MULTIMODALITY CANCER THERAPY;

ADENOVIRIDAE; ANTIMETABOLITES, ANTINEOPLASTIC; BILE DUCT NEOPLASMS; CHOLANGIOCARCINOMA; COMBINED MODALITY THERAPY; CYTOSINE DEAMINASE; FLUCYTOSINE; FLUOROURACIL; GENE THERAPY; GENETIC VECTORS; HUMANS; NUCLEOSIDE DEAMINASES; PRODRUGS; RADIOTHERAPY, HIGH-ENERGY; TUMOR CELLS, CULTURED;

EID: 0032057198     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(98)80024-3     Document Type: Article

References (45)

1. Klatskin G. Adenocarcinoma of the hepatic ducts at its bifurcation within the porta hepatis: An unusual tumor with distinctive clinical and pathological features. Am J Med 1965; 38:241-256.
2. Schoenthaler R, Castro JR, Halberg FE, Phillips TL. Definitive postoperative irradiation of bile duct carcinoma with charged particles and/or photons. Int J Radiat Oncol Biol Phys 1993;27:75-82.
3. Mittal B, Duetsch M, Iwatsuki S. Primary cancers of extra-hepatic biliary passages. Int J Radiat Oncol Biol Phys 1985; 11:849-854.
4. Pitt H, Dooley W, Yeo C, Cameron JL. Malignancies of the biliary tree. Curr Probl Surg 1995;32:1-100.
5. Pitt HA, Nakeeb A, Abrams RA, Coleman J, Piantadosi S, Yeo CA, Lillemoe KD, Cameron JL. Perihilar cholangiocarcinoma: Postoperative radiotherapy does not improve suvival. Ann Surg 1995;221;788-798.
6. Vauthey JN, Blumgart LH. Recent advances in the management of cholangiocarcinomas. Semin Liver Dis 1994;14:109-114.
7. Saunders K, Longmire W, Tomkins R, Chavez M, Cates J, Roslyn J. Diffuse bile duct tumors: Guidelines for management. Am Surg 1991;57:816-820.
8. Yeo CJ, Pitt HA, Cameron JL. Cholangiocarcinoma. Surg Clin North Am 1990;70:1429-1447.
9. Van Der Hul RL, Plaisier PW, Lameris JS, Veeze-Kuijpers B, Van Blankenstein M, Terpstra OT. Proximal cholangiocarcinoma: A multidisciplinary approach. Eur J Surg 1994;160:213-218.
10. Hsue V, Wong CS, Moore M, Erlichman C, Cummings BJ, MacLeod M. A phase I study of combined radiation therapy with 5-fluorouracil and low dose folinic acid in patients with locally advanced pancreatic or biliary carcinoma. Int J Radiat Oncol Biol Phys 1996;34:445-450.
11. Veeze-Kuijpers B, Meerwaldt JH, Lameris JS, Van Blankenstein M, Van Putten WLJ, Terpstra OT. The role of radiotherapy in the treatment of bile duct carcinoma. Int J Radiat Oncol Biol Phys 1990;18:63-67.
12. Gonzalez Gonzalez D, Gerard JP, Maners AW, De La Lande-Guyaux B, Van Dijk-Milatz A, Meerwaldt JH, Bosset JF, Van Dijk JDP. Results of radiation therapy in carcinoma of the proximal bile duct (Klatskin tumor). Semin Liver Dis 1990; 10:131-141.
13. Verbeek PCM, Van Leeuwen DJ, Van Der Heyde MN, Gonzalez Gonzalez D. Does additive radiotherapy after hilar resection improve survival of cholangiocarcinoma? An analysis of sixty-four patients. Ann Chir 1991;45:350-354.
14. Busse PM, Stone MD, Sheldon TA, ChaffeyJT, Cady B, McDermott WV, Bothe A, Jenkins R, Steele G. Intraoperative radiation therapy for biliary tract carcinoma: Results of a 5-year experience. Surgery. 1989;105:724-733.
15. Freeman SM, Whartenbury KA, Freeman JL, Abboud CN, Marrogi AJ. In situ use of suicide genes for cancer therapy. Semin Oncol 1996;23:31-45.
16. Mullen C. Metabolic suicide genes in gene therapy. Pharmacol Ther 1994;63:199-207.
17. Harris JD, Gutierrez AA, Hurst HC, Sikora K, Lemoine NR. Gene therapy for cancer using tumor-specific prodrug activation. Gene Ther 1994;1:170-175.
18. Wills KN, Huang W, Harris MP, Machemer T, Maneval DC, Gregory RJ. Gene therapy for hepatocellular carcinoma: Chemosensitivity conferred by adenovirus-mediated transfer of the HSV-1 thymidine kinase gene. Cancer Gene Ther 1995;2:191-197.
19. McKie EA, MacLean AR, Lewis AD, Cruickshank G, Rampling R, Barnett SC, Kennedy PGE, Brown SM. Selective in vitro replication of herpes simplex virus type I (HSV-1) icp34.5 null mutants in primary human CNS tumors - Evaluation of a potentially effective clinical therapy. Br J Cancer 1996;74:745-752.
20. Yang L, Hwang R, Pandit L, Gordon EM, Anderson WF, Parekh D. Gene therapy of metastatic pancreas cancer with intraperitoneal injections of concentrated retroviral herpes simplex thymidine kinase vector supernatant and ganciclovir. Ann Surg 1996;224:405-417.
21. Chen S, Li Chen XH, Kosai K, Finegold MJ, Rich S, Woo SLC. Combination gene therapy for liver metastasis of colon carcinoma in vivo. Proc Natl Acad Sci USA 1995;92:2577-2581.
22. Austin EA, Huber BE. A first step in the development of gene therapy for colorectal carcinoma: Cloning, sequencing, and expression of Escherichia coli cytosine deaminase. Mol Pharmacol 1992;43:380-387.
23. Huber BE, Austin EA, Good SS, Knick VC, Tibbels S, Richards C. In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase. Cancer Res 1993;53:4619-4626.
24. Huber BE, Austin EA, Richards CA, Davis ST, Good SS. Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with cytosine deaminase gene: Significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. Proc Natl Acad Sci USA 1994;91:8302-8306.
25. Wei K, Huber BE. Cytosine deaminase gene as a positive selection marker. J Biol Chem 1996;271:3812-3816.
26. Hoganson DK, Batra RK, Olsen JC, Boucher RC. Comparison of the effects of three different toxin genes and their levels of expression on cell growth and bystander effect in lung adenocarcinoma. Cancer Res 1996;56:1315-1323.
27. Kanai F, Lan K, Shiratori Y, Tanaka T, Ohashi M, Okudaira T, Yoshida Y, Wakimoto H, Hamada H, Nakabayashi H, Tamaoki T, Omata M. In vivo gene therapy for α-fetoprotein-producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene. Cancer Res 1997;57:461-465.
28. Richards CA, Austin EA, Huber BE. Transcriptional regulatory sequences of carcinoembryonic antigen: Identification and use with cytosine deaminase for tumor-specific gene therapy. Human Gene Ther 1995;6:881-893.
29. Rowley S, Lindauer M, Gebert JF, Haberkorn U, Oberdorfer F, Moebius U, Herfarth C, Schackert H. Cytosine deaminase gene as a potential tool for the genetic therapy of colorectal cancer. J Surg Oncol 1996;61:42-48.
30. Trinh QT, Austin EA, Murray DM, Knick VC, Huber BE. Enzyme/prodrug gene therapy: Comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme prodrug systems in a human colorectal cell line. Cancer Res 1995;55:4808-4812.
31. Ohwada A, Hirschowitz EA, Crystal RG. Regional delivery of an adenovirus vector containing the Escherichia coli cytosine deaminase gene to provide local activation of 5-fluorocytosine to suppress the growth of colon carcinoma metastatic to liver. Human Gene Ther 1996;7:1567-1576.
32. Mullen CA, Coale M, Lowe R, Blaese RM. Tumor expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor. Cancer Res 1994;54:1503-1506.
33. Khil MS, Kim JH, Mullen CA, Kim SH, Freytag SO. Radiosensitization by 5-fluorocytosine of human colorectal carcinoma in culture transduced with cytosine deaminase gene. Clin Cancer Res 1996;2:53-57.
34. Sougawa M, Akagi K, Murata T, Kawasaki S, Sawada S, Yoshii G, Tanaka Y. Enhancement of radiation effects by acyclovir. Int J Radiat Oncol Biol Phys 1986;12:1537-1540.
35. Kim JH, Kim SH, Brown SL, Freytag SO. Selective enhancement by antiviral agent of the radiation-induced cell killing of human glioma cells transduced with HSV-tk gene. Cancer Res 1994;54:6035-6056.
36. Kim JH, Kim SH, Kolozsvary A, Brown SL, Kim OB, Freytag SO. Selective enhancement of radiation response of herpes simplex virus thymidine kinase transduced 91 gliosarcoma cells in vitro and in vivo by antiviral agents. Int J Radiat Oncol Biol Phys 1995;33:861-868.
37. Rogulski KR, Kim JH, Kim SH, Freytag SO. Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity. Human Gene Ther 1997;8:73-85.
38. Rosenfeld ME, Feng M, Michael SI, Siegal GP, Alvarez RD, Curiel DT. Adenoviral-mediated delivery of the herpes simplex virus thymidine kinase gene selectively sensitizes human ovarian cells to ganciclovir. Clin Cancer Res 1995;1:1571-1580.
39. Becker TC, Noel RJ, Coats WS, Gomez-Foix AM, Alam T, Gerard RD, Newgard CB. Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol 1994;43:161-188.
40. Haberkorn U, Oberdorfer F, Gebert J, Morr I, Haack K, Weber K, Lindauer M, van Kaick G, Schackert HK. Monitoring gene therapy with cytosine deaminase: In vitro studies using tritiated 5-fluorocytosine. J Nucl Med 1996;37:87-94.
41. Vickers SM, Phillips JO, Bynon JS, Thompson JA, Curiel DT. In vivo gene transfer to the human biliary tract. Gene Ther 1996;3:825-828.
42. Chapman RWG, Arborgh BAM, Rhodes JM, Summerfield JA, Dick R, Scheuer PJ, Sherlock S. Primary sclerosing cholangitis: A review of its clinical features, cholangiography and hepatic histology. Gut 1980;21:870-877.
43. Rosen CB, Nagorney DM. Cholangiocarcinoma complicating primary sclerosing cholangitis. Semin Liver Dis 1991; 11:26-30.
44. Rosenfeld MA, Vickers SM, Raben D, Wang M, Sampson LK, Feng M, Jaffee E, Curiel DT. Pancreatic carcinoma cell killing via adenoviral mediated delivery of the herpes simplex virus thymidine kinase gene. Ann Surg 1997;225:609-620.
45. Pederson LC, Buchsbaum DJ, Vickers SM, Kancharla SR, Mayo MS, Curiel DT, Stackhouse MA. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo. Cancer Res 1997;57:4325-4332.